Market Closed

PMCB
PharmaCyte Biotech
$ 6.68
-12.54%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

PharmaCyte Biotech News

Latest PharmaCyte Biotech Stock News & PMCB Headlines

PharmaCyte Biotech Reports Strong Cash and Asset Position
2 days ago | businesswire.com
PharmaCyte Biotech, Inc. Announces Reverse Stock Split
4 days ago | businesswire.com
Nuvilex (NASDAQ:PMCB) Trading 5.3% Higher – Here’s Why
7 months ago | defenseworld.net
Comparing Nuvilex (NASDAQ:PMCB) & Avadel Pharmaceuticals (NASDAQ:AVDL)
a year ago | defenseworld.net
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
a year ago | businesswire.com
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
a year ago | businesswire.com
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
a year ago | businesswire.com
MyMD Pharmaceuticals Secures Strategic Investments
2 years ago | businesswire.com
PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.
3 years ago | businesswire.com
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology
3 years ago | businesswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

PMCB
PharmaCyte Biotech
$ 6.68
-12.54%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago